Xenetic Biosciences (NASDAQ:XBIO) will report on Q2 2022.
IFF Chief Financial And Business Transformation Officer Glenn Richter To Retire Year End 2024, Succession Process Has Been Initiated To Evaluate Internal And External Candidates To Succeed CFO
IFF (NYSE:IFF) today announced that Glenn Richter, IFF's Chief Financial and Business Transformation Officer, plans to retire Dec. 31, 2024 after a three-year tenure with the company. A succession process has been
